Etoposide is a prescription medicine for the treatment of small cell carcinoma of the lung, acute monocytic and myelomonocytic leukaemia, Hodgkin’s disease, and Non-Hodgkin’s lymphoma 1.
Etoposide is widely approved, including by the FDA in the USA, the EMA in the EU, and the MHRA in the UK.
